Does REMDESIVIR Cause Injection site extravasation? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Injection site extravasation have been filed in association with REMDESIVIR (Veklury). This represents 0.2% of all adverse event reports for REMDESIVIR.
21
Reports of Injection site extravasation with REMDESIVIR
0.2%
of all REMDESIVIR reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site extravasation From REMDESIVIR?
Of the 21 reports, 2 (9.5%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which REMDESIVIR Alternatives Have Lower Injection site extravasation Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN